ray, you and Jtower are the 2 bs'ers on this board.. Franz is another one, but he's already left the building...it is time to stop your bs and move on to other MB, because every one knows you're full of #$%$.
a Chinese company, registered in Caymen, and stock keeps making new 52wk high.. WX is one article away from bogus SA author accusing WX of accounting frauds.. stock could drop 50% in pre-market, and by the time retail investors try to sell their shares, it is too late.. lawfirms will announced many law suits and stock continues on the down trend...
WS fraudsters like Muddy Waters and others are targeting Chinese companies to take them down while shorting the stock....wait and see... GL
OMED, GALE, RMTI, KERX, and EXEL.. this stock doesn't behave like 80% institutional ownership, and insiders selling incites high volatility in the recent trading sessions..
why the F this POS won't hold $24 just for 1 day.. now I wonder if it could hold $23 by the eod.. so the next data point is going to be 2H2014.. unless there's an open M&A discussion, CLDX stock is going sideway the rest of the way ???? another concern I have is that many authors started backing away and distanced themselves from their previous analyses, it seems that they have serious reservations from cancer vaccine research..
at least it stay above $1 from the LOD.. today is a good day for buyers to invest in high quality stocks.. unless smart investors know something that retail investors don't.. this is frustrating to say the least...
my bet will be no change in FED policy for now.. if taper is announced, market crash could happen and shopping season could be halted.. upcoming earning reports will not meet expectations and equity markets drop further.. this will destablizing the world economy.. will see if the FED is listening to my free advise.. LOL
Wall Street is a scam street to allow an unknown, unregistered analyst to make bogus coverage with a low target stock price. If they can do that with RMTI, other biotech companies are not safe:
Rockwell Medical (RMTI) stock plummeted to below 10 on the stock market today after an analyst questioned the validity of the firm's clinical trials, despite another analyst's rising to the defense.
Late Monday, Brean Capital analyst Jonathan Aschoff initiated coverage of the stock with a sell rating and a price target of 4. Rockwell Medical stock was down 25% in midday trading Tuesday, near 10.
Aschoff was unimpressed by the recently completed clinical trials of Triferic, a drug to treat iron deficiency in patients with chronic kidney disease receiving dialysis.
"A key employee termination and resulting lawsuit further speaks to inadequate Triferic testing, in our view, where a former (vice president) of drug development and medical affairs warned Rockwell that its Phase 2b trial did not adequately show efficacy or dose-ranging information to proceed directly to Phase 3," he wrote.
He projected flat future sales for the company, which drew $50 million in revenue last year from its dialysis-related products.
Tuesday morning, Summer Street analyst Carol Werther advised buying on the stock's weakness, and dismissed Aschoff's objections. "Every single accusation Yocum (the former employee) made has been proven false by clinical facts. The dose worked. Patients were safe," Werther wrote in a research note.
Werther maintained a buy rating on Rockwell stock, with a price target of 25.
clinically is a good news, did AGEN project the potential revenues for this exp.therapy ? stock price doesn't seem to respond well to the recent good news released by the company...AGEN market caps should be 500Mil by now.. Unfortunately, MMs are keeping $90milin market caps with $35mil in cash and a rich pipeline of cancer cure products.. what can you do when Wall Street cartels not to let stock price holds above $3/shr.
take your bulls$%t somewhere else.
I'm long and tend to agree with you... this movie is a replay..once a month, this stock jumped above $3 shortly, and then pulled back below $2.5 the rest of the month.. apparently shorts are holding this stock down, and no demand to force shorts to cover their positions, unless M&A announcement..
I know who I am, I only use one ID, not like these paid pumpers trying to hide behind different IDs to pump and mislead investors. I talked as a 3rd person to present my point, my position is consistent.. over-pumping is not healthy. Only fools married to one stock. Smart investors know when the stock is over-valued and when the stock is a fair value..
I'm long 5000 shrs as of yesterday.. but I will exit if it drops below 20's.. the ultimate goal is to get 1 product approved by FDA and generating revenue before speculating $bil in revenues or M&A as some of pumpers are speculating..
if his bashing drives CLDX down, then it is time to learn a thing or two from him.. instead of fantasizing these bs speculations that not helping stock moves 1 cent in your direction.. you guys need medications and rehabs.. Casa knows what he's doing...
stop promoting these baseless non-sense speculations...let focus on the science and FDA approval..
90% institutional ownership won't help to defend their investments ? that is what I was hoping, but stock prices show otherwise..